ALKEM Rolling Returns

Over 7 years, Alkem Laboratories Ltd. has been through 45 separate 7 years holding periods — one starting every month. The median returned 16.1% a year, the worst 11.6% and the best 20.4%. A rolling return measures every possible start date instead of one, which is why it answers a question a single headline CAGR cannot: how much the outcome depended on when you happened to buy.

No — not in any of the 45 7 years periods the record covers. The weakest of them still compounded at 11.6% a year. That is a statement about the past, not a guarantee about any future 7 years, and it is measured only over the years Alkem Laboratories Ltd. has been listed.

7.4% a year, for the five years beginning December 2017. For contrast the best 5 years returned 29.0% a year, starting August 2019, and the median across all 69 periods was 15.7%. The gap between those two numbers is the part of the outcome that came down to timing rather than to the company.

On this record, yes. 1 year outcomes ranged from -22.6% to 75.7% a year — a spread of 98.2%. 7 years outcomes ranged from 11.6% to 20.4%, a spread of 8.8%. Longer holding periods narrowed the range of results, which is the usual pattern and the reason this page publishes every window rather than one. Narrowing the range is not the same as removing the risk.

In 95.6% of the 45 7 years periods both series cover. Each window is compared against the index over the identical months, not against an assumed index return, so the comparison is a like-for-like record rather than a model.

Windows step forward one month at a time on month-end closing prices adjusted for dividends and stock splits, so dividends are treated as reinvested. A window length is only published once there are at least twelve complete windows behind it — fewer than that describes an anecdote, not a distribution. Overlapping windows share months by construction, which is what makes this a description of the actual history of Alkem Laboratories Ltd. rather than a sample of independent trials. Companies that delisted are not on this site at all, a survivorship bias worth holding in mind.

That is not a question this page answers, and we do not make recommendations. What it can show you is the full range of what every holding period in the listed history of Alkem Laboratories Ltd. actually produced — including the worst ones, which most performance figures leave out. Those are records of what happened, not forecasts. A stock that never had a losing decade may still have one, and holding a single company is a materially different risk from holding an index.